Johnson & Johnson's 3Q profit up on higher prescription drug sales, lower research spending

  • by: LINDA A. JOHNSON , Associated Press
  • Updated: October 15, 2013 - 2:20 PM

Rising prescription drug sales and continued recovery of Johnson & Johnson's beleaguered consumer health business in the third quarter helped the health care giant overcome slumping medical device sales.

  • 0
  • Comments

There are currently no comments for this article

Comment on this story   |   Be the first to comment

Be the first to comment

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT